CASP1 single-nucleotide polymorphisms were associated with changes in NF-κB signaling and development of other non-Hodgkin lymphomas, including diffuse-large B cell lymphomas and small lymphocytic lymphoma/chronic lymphocytic leukemia (59). Here, CASP1 is linked to non-Hodgkin lymphoma.